Israel: 90% of patients treated with new drug discharged in 5 days
The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover…
The Phase II trial for an Israeli COVID drug saw some 29 out of 30 patients, moderate to serious, recover…